These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495 [TBL] [Abstract][Full Text] [Related]
31. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer. Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746 [TBL] [Abstract][Full Text] [Related]
32. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy. Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418 [TBL] [Abstract][Full Text] [Related]
33. The feasibility and safety of cryoablation as an adjuvant therapy with transurethral resection of bladder tumor: A pilot study. Liu S; Zhang L; Zou L; Wen H; Ding Q; Jiang H Cryobiology; 2016 Oct; 73(2):257-60. PubMed ID: 27393244 [TBL] [Abstract][Full Text] [Related]
34. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience. de Crevoisier R; Ammor A; Court B; Wibault P; Chirat E; Fizazi K; Theodore C; Yom SS; Haie-Meder C Radiother Oncol; 2004 Aug; 72(2):147-57. PubMed ID: 15376367 [TBL] [Abstract][Full Text] [Related]
35. Histological evaluation of superficial bladder tumors treated by Nd-YAG laser and transurethral resection. Vicente J; Salvador J; Laguna P; Algaba F Eur Urol; 1991; 20(3):192-6. PubMed ID: 1823041 [TBL] [Abstract][Full Text] [Related]
36. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637 [TBL] [Abstract][Full Text] [Related]
37. Can tumor recurrence be reduced with plasma-kinetic vaporization of the area around the tumor in nonmuscle invasive bladder cancer? Yılmaz Y; Kahya MC; Dilek FH; Köse O; Özcan S; Can E; Akın Y; Ergani B; Dindar AS Investig Clin Urol; 2018 Jul; 59(4):223-231. PubMed ID: 29984336 [TBL] [Abstract][Full Text] [Related]
38. [The surgical results in malignant bladder tumors using the Scalpel-1 carbon-dioxide laser]. Dmitriev BV; Nikol'skiĭ AD; Latyshev MM; Zolin VP; Sanevich RA Urol Nefrol (Mosk); 1997; (1):25-8. PubMed ID: 9123661 [TBL] [Abstract][Full Text] [Related]
39. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer]. Flamm J; Kühnel W; Dona S Urologe A; 1989 Mar; 28(2):99-102. PubMed ID: 2655259 [TBL] [Abstract][Full Text] [Related]
40. Preoperative doxorubicin instillation in recurrent superficial bladder cancer. Kubota Y; Noguchi S; Shuin T; Moriyama M; Hosaka M; Satomi Y; Furuhata A; Kondo I; Sakuramoto T; Yao M Cancer Chemother Pharmacol; 1987; 20 Suppl():S56-9. PubMed ID: 3664944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]